MJNA (Medical Marijuana) EBITDA Margin %: -507.80% (As of Dec. 2017)


What is Medical Marijuana EBITDA Margin %?

Medical Marijuana MJNA +100.00% EBITDA Margin % is -507.80% as of Dec. 2017.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Medical Marijuana's EBITDA for the six months ended in Dec. 2017 was $-134.69 Mil. Medical Marijuana's Revenue for the six months ended in Dec. 2017 was $26.52 Mil. Therefore, Medical Marijuana's EBITDA margin for the quarter that ended in Dec. 2017 was -507.80%.

Medical Marijuana  (OTCPK:MJNA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Medical Marijuana EBITDA Margin % Related Terms

Medical Marijuana EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Medical Marijuana's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Marijuana EBITDA Margin % Chart

Medical Marijuana Annual Data
Trend Dec09 Dec10 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
EBITDA Margin %
Get a 7-Day Free Trial -19.70 -23.22 -1,079.85 -183.40 -507.80

Medical Marijuana Semi-Annual Data
Dec09 Dec10 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
EBITDA Margin % Get a 7-Day Free Trial -19.70 -23.22 -1,079.85 -183.40 -507.80

MJNA vs UPC, ERBB, KAYS: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medical Marijuana's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medical Marijuana EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medical Marijuana's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Medical Marijuana's EBITDA Margin % falls into.


Medical Marijuana EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Medical Marijuana's EBITDA Margin % for the fiscal year that ended in Dec. 2017 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2017 )/Revenue (A: Dec. 2017 )
=-134.685/26.523
=-507.80 %

Medical Marijuana's EBITDA Margin % for the quarter that ended in Dec. 2017 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2017 )/Revenue (Q: Dec. 2017 )
=-134.685/26.523
=-507.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -507.80% mean?
Medical Marijuana (MJNA) has a EBITDA Margin % of -507.80% as of Dec. 2017. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medical Marijuana and its competitors.
Is Medical Marijuana's EBITDA Margin % too high?
Medical Marijuana's current EBITDA Margin % is -507.80%.
How does Medical Marijuana's EBITDA Margin % compare to UPC and ERBB?
Medical Marijuana's EBITDA Margin % of -507.80% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.44, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medical Marijuana and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Marijuana's current EBITDA Margin % is -507.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Marijuana stock overvalued right now?
Medical Marijuana (MJNA) has a current EBITDA Margin % of -507.80%. The current EBITDA Margin % is -507.80%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Medical Marijuana (MJNA), the current EBITDA Margin % is -507.80% as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medical Marijuana Business Description

Address 2384 La Mirada Drive, Vista, CA, USA, 92081
Medical Marijuana Inc is engaged in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol and other products containing CBD-rich hemp oil. The company's products are used by pharmaceutical, nutraceutical, and cosmeceutical industries. Some of its products are CBD Capsules, CBD Tinctures, Vaporizers, and Hemp foods among others. The company operates through Retail and Wholesale division; Direct Sales division; and Manufacturing and Production Division.